Ziegler Christoph Samuel

SEC Form 4 insider trading activity

Ziegler Christoph Samuel has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Oct 21, 2026.

On the most recent filing, Ziegler Christoph Samuel is listed as Director at Veraxa Biotech AG - Post de-SPAC. Inside the rolling window, Ziegler Christoph Samuel reported 1 open-market purchase totaling $33K in VRXA and no open-market sales.

Companies traded

Other insiders at VRXA

Insider Buying

$33K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
VRXA
Ziegler Christoph Samuel
Purchase$33KOct 21SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Ziegler Christoph Samuel made?

Ziegler Christoph Samuel has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Ziegler Christoph Samuel trade?

Ziegler Christoph Samuel has filed SEC Form 4 disclosures for 1 company, including VRXA.

When was Ziegler Christoph Samuel's most recent SEC Form 4 filing?

Ziegler Christoph Samuel's most recent SEC Form 4 filing on Tracefour is dated Oct 21, 2026.

What is Ziegler Christoph Samuel's total buy and sell value in the current window?

Inside the rolling retention window, Ziegler Christoph Samuel bought $33K and sold $0 based on SEC Form 4 filings.

What was Ziegler Christoph Samuel's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 30,000 VRXA shares on 2026-10-20, worth $33K, per SEC Form 4 filings.